Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Natco Pharma sees major leadership exit in RnD, demand & supply, quality

Natco Pharma Executive VP - Technology Transfer, Intellectual Property Rights & Regulatory Affairs (API), Dr Ramesh Dandala, superannuates

Ruchika Sharma4 April 2025 1:30 PM IST

Telangana: Natco Pharma has announced the superannuation of Dr Ramesh Dandala, Executive Vice President - Technology Transfer, Intellectual...

Shilpa Medicare arm partners with Orion Corporation for Recombinant Human Albumin for European Market

Shilpa Medicare marketing partner Amneal Pharma unveils multiple myeloma treatment Boruzu

Ruchika Sharma4 April 2025 12:30 PM IST

Karnataka: Shilpa Medicare has announced that the Company's marketing partner, Amneal Pharmaceuticals, has launched BORUZU, (Bortezomib...

Novo Nordisk reshapes Executive management team

Ruchika Sharma4 April 2025 11:30 AM IST

Novo Nordisk HA has announced that Camilla Sylvest has decided to leave the company after a distinguished career of 28 years with the Company,...

Bayer AG arm Vividion Therapeutics doses first patient in Phase I study of Inhibitor for advanced solid tumors treatment

Ruchika Sharma4 April 2025 10:30 AM IST

San Diego: Vividion Therapeutics, Inc. has announced that the first patient has been dosed in a Phase I clinical trial evaluating VVD-159642, an...

Novartis eyes Avidity Biosciences in potential takeover: Report

Novartis receives USFDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy

Ruchika Sharma3 April 2025 4:30 PM IST

East Hanover: Novartis has received accelerated approval from the US Food and Drug Administration (FDA) for Vanrafia...

Martin A. Makary sworn in as FDA Commissioner

Ruchika Sharma3 April 2025 3:33 PM IST

Renowned surgeon-scientist and health policy expert, Martin A. Makary, M.D., M.P.H., took the oath of office to become the 27th Commissioner of Food...

AbbVie seeks USFDA nod for combination regimen of Venclexta, Acalabrutinib

USFDA grants orphan drug designation to Sanofi Rilzabrutinib for two rare diseases

Ruchika Sharma3 April 2025 2:45 PM IST

Paris: Sanofi has announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to Rilzabrutinib, an...

Sanofi to expand respiratory vaccines pipeline with acquisition of Vicebio

Lupin UK arm acquires Renascience Pharma for over Rs 138 crore

Ruchika Sharma3 April 2025 1:30 PM IST

Mumbai: Lupin Healthcare (UK) Limited, the wholly owned subsidiary of global pharma major Lupin Limited, has announced the acquisition of ...

Bajaj Healthcare CFO Dayashankar Patel resigns

Ruchika Sharma3 April 2025 12:30 PM IST

Thane: Bajaj Healthcare has announced that Dayashankar Patel, has tendered his resignation from the position of Chief Financial Officer (‘CFO’),...

Girl With Fever Given Rabies Vaccine, Probe Ordered

Gland Pharma receives USFDA nod for pain management injection Acetaminophen

Ruchika Sharma3 April 2025 11:30 AM IST

This Product is indicated for the management of mild to moderate pain in adult and pediatric patients 2 years and older.

JnJ seeks indication extension of Akeega from EMA for adults with metastatic hormone-sensitive prostate cancer, HRR gene alterations

JnJ closes Intra-Cellular Therapies acquisition

Ruchika Sharma3 April 2025 10:30 AM IST

New Brunswick: Johnson & Johnson has announced it has completed its acquisition of Intra-Cellular Therapies, Inc. Intra-Cellular Therapies is...

Mass layoffs begin at FDA, CDC, other US health agencies

Ruchika Sharma2 April 2025 5:16 PM IST

The Trump administration has started mass layoffs of 10,000 employees across U.S. health agencies, with reports indicating that security personnel...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok